CommentaryLoss to follow-up of preterm and very preterm babies
References (8)
- et al.
Follow-up of preterm children: important to document dropouts
Lancet
(1995) Australian collaborative trial of antenatal thyrotropin-releasing hormone (ACTOBAT) for the prevention of neonatal respiratory disease
Lancet
(1995)- et al.
and the ACTOBAT Study Group. Australian collaborative trial of antenatal thyrotropin releasing hormone: adverse effects at 12-month follow-up
Pediatrics
(1997) The credibility of the ACTOBAT follow-up study
Pediatrics
(1997)
There are more references available in the full text version of this article.
Cited by (6)
Neurodevelopmental outcomes of neonates with medically and surgically treated necrotizing enterocolitis
2007, Archives of Disease in Childhood: Fetal and Neonatal EditionThe legal landscape at the threshold of viability for extremely premature infants: A nursing perspective, part II
2005, Journal of Perinatal and Neonatal NursingMeasuring later health status of high risk infants: Randomised comparison of two simple methods of data collection
2001, British Medical JournalNeurodevelopment and predictors of outcomes of children with birth weights of less than 1000 g 1992-1995
2000, Archives of Pediatrics and Adolescent MedicineDevelopment of former preterm infants with a birthweight below 1500 g: Concept and results of a follow-up programme up to school age in Central Switzerland
1999, Schweizerische Medizinische Wochenschrift
Copyright © 1998 Elsevier Ltd. All rights reserved.